Target intelligence / Profile preview

Phospholipase B domain-containing protein 2 (PLBD2)

Target
PLBD2
Molecular classification
Enzyme (predicted, phospholipase B family), N-terminal nucleophile hydrolase (NTN hydrolase clan), Lysosomal protein, Other (orphan enzyme; substrate specificity unknown)
01

Overview

Phospholipase B domain-containing protein 2 (PLBD2) is a human lysosomal protein predicted to belong to the phospholipase B enzyme family, although its physiological substrate and precise biological function remain unconfirmed[3][1][2]. Structurally, it is an N-terminal nucleophile (NTN) hydrolase, sharing features with certain amidases and peptidases, and requires post-translational modifications including signal peptide cleavage, glycosylation, and proteolytic processing for maturation and lysosomal targeting[1][2]. PLBD2 is expressed in multiple tissues, including kidney and brain, and localizes primarily to the lysosome[5][2][3]. While mutations in the gene may theoretically contribute to lysosomal storage disorders, no definitive clinical phenotype has been ascribed[1]. The gene has several paralogs, notably PLBD1, and evidence suggests these enzymes diverged significantly following an ancient gene duplication event[1][3]. Despite extensive conservation of functional motifs, the actual activity and natural substrate of PLBD2 remain largely undetermined, and there are currently no known drugs or therapies that target this protein[1][2][3].

Other names
Putative phospholipase B-like 2p7676 kDa proteinLAMA-like protein 2Lamina ancestor homolog 2mannose-6-phosphate protein associated protein p76PLB homolog 2 (Dictyostelium)32 kDa form45 kDa formPLB homolog 2PLB-like 2phospholipase B-like 2 32 kDa formphospholipase B-like 2 45 kDa form
02

Biological functions

Predicted phospholipase activity (putative)Phospholipid catabolic process (predicted)Lysosomal protein maturation and targetingPotential involvement in degradation of cellular macromoleculesExact physiological substrate and function remain unconfirmed
03

Disease associations

Lysosomal storage disease (theoretical, not clinically proven)Gallbladder papillomatosis (gene-disease association, limited evidence)Sea-blue histiocyte disease (association, weak evidence)Other (general links to lysosomal dysfunction possible, but not established)

Beyond the preview

Go deeper on Phospholipase B domain-containing protein 2 (PLBD2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phospholipase B domain-containing protein 2 (PLBD2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call